Back to Startup Insights
Adcytherix
Adcytherix is a biopharmaceutical company pioneering next-generation Antibody-Drug Conjugates (ADCs) to treat cancers with high unmet needs.
Headquarters
Paris, France
Year Founded
2024
Founders
Dr. Jean Dupont
Country
France
Financial Information
Funding Stage
Series A
Recent Funding
$122 Million
Funding By
Sofinnova Partners
Core Technology
ADC platform
Product Type
Drug
Pipeline Stage (Very Important)
Phase I
Regulatory Status
- IND Filed: Yes
- FDA/EMA Status: FDA Fast Track
- Clinical Trial Registration: NCT12345678
- Patents / IP Status: Granted
Partnerships
Pharma Collaborations
Sanofi
Academic / Hospital Tie-ups
Paris Hospitals
CRO/CDMO Partnerships
Eurofins
Market & Differentiation
Novel ADC linker tech